{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwLefqZQKDA","lastupdate":"2022-09-15T00:00:00.000Z","update_date":"2022-09-15T00:00:00.000Z","lastModified":"Apr 25, 2025","active":1,"confidence_score":92,"confidence_score_reason":"markets, not claimed","urlname":"pharmocan","minimal_profile":null,"status":"Public","fullstatus":"Public on TASE on Dec, 2018<br>","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$zGBwzdybzU8cf5K2lIr3OMCQsqhWLCJbPwIuhVWix3KsnBPYY2ykHA","name":"Pharmocann","oneliner":"Medical Cannabis Cultivation and R&D","registrar":"514125749","website":"http://pharmocann.com/","careerspage":"https://pharmocann.com/careers","founded_month":4,"founded_year":2008,"formernames":[],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UC7Pti3NxrIprDie9JP2kVBg","facebook":"https://www.facebook.com/pharmocann","linkedin":"https://www.linkedin.com/company/18450262","instagram":"https://www.instagram.com/pharmocann"},"social":["https://www.instagram.com/pharmocann","https://www.youtube.com/channel/UC7Pti3NxrIprDie9JP2kVBg","https://www.linkedin.com/company/18450262","https://www.facebook.com/pharmocann"],"flattenedsociallinks":"https://www.instagram.com/pharmocann|https://www.youtube.com/channel/UC7Pti3NxrIprDie9JP2kVBg|https://www.linkedin.com/company/18450262|https://www.facebook.com/pharmocann","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"1-10","employees_exact":8,"patent":0,"raised":690000,"stage":"Public","public_stage":"Public","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Pharmocann develops and produces Israeli medical cannabis on a farm located in the valley of Jezreel, the Galilee. The farm has hothouses for cannabis growth and propagation; a hothouse for the research and development of various cannabis strains; and other facilities required for the cultivation, harvesting, and production of medical cannabis.\n\nThe company is also a developer of medical marijuana cultivation centers and dispensaries. Pharmocann has established a strategic partnership with medical cannabis labs to produce standardized, validated, and GMP-manufactured medical cannabis products. Its line of products includes oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains. \n\nPharmocann’s latest developments include hydrogel products for the treatment of certain painful diseases, acute dermatological diseases, and inflammatory bowl diseases. Pharmocann serves more than 3,000 patients a month and yields about two tons of medical cannabis yearly.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97249533757","country":null,"address":{"israeli":[{"id":"68c797c7-e84d-4b58-8491-824176fb08bb","city":"Kiryat Tiv'on","type":null,"address":"Kiryat Tiv'on, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"North District","news":[{"id":"h1M56bJv0qpJrvbqNXX7auqjkc4XuAWDfqMagPbhqxx9MLhf3LlnXg","date":"Sep 14, 2022","link":"https://www.sponser.co.il/Article.aspx?_atscid=7_134353_204082920_2266549_0_Txtetaxjxdshwhus8sp&ArticleId=109628","source":"www.sponser.co.il","visible":1,"analysis":{"tags":"fundraising","company":"פארמוקן","layoffs":null,"summary":"פארמוקן, a medical cannabis company in Israel, has raised 6.5 million shekels through a public stock offering. The company received additional orders totaling 14.8 million shekels, but chose to accept a lower amount. The CEO of פארמוקן, Liran Helfon, participated in the offering and purchased stocks worth 1.6 shekels. The fundraising was led by Valio Base, which also increased its stake in the company. פארמוקן has been a pioneer in the medical cannabis field in Israel since its establishment in 2008. Recent changes, including the entry of Yair Lerner, have raised questions about the companys future.","partners":null,"customers":null,"investors":"יריב לרנר","confidence":8,"key_topics":["גיוס","מניות","השקעה","חלוצות העשייה","שינויים"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"6.5 million shekels","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pyHvE0BoLzAxv9g4bAlPOv4TS4lhIxXicxZC3x6sJvrZ4QCj9Pchur","news_summary":"ספונסר תקלה","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"FLKttgjnxb5Vb1UzBIxu4aB0OvJXIoQI2H7ZKptlBmUvhuF85hcdXZ","date":"Sep 13, 2022","link":"https://www.calcalist.co.il/market/article/bjgo00r3es","source":"www.calcalist.co.il","visible":1,"analysis":{"tags":"Investment, Layoffs","company":"פארמוקן","layoffs":"Not specified","summary":"Israeli cannabis company Pharmocann is planning to issue up to 70% of its existing shares at a minimum price of half a shekel per share, despite trading at more than one shekel yesterday. The companys value has plummeted to 7 million shekels, a skeleton stock exchange value. The company is burning cash at a rate of 5.2 million shekels a year and has only 1.2 million shekels left in its cash box. The company has been making heavy losses and has been hit by a fungus in its crops. The company has also seen a series of personnel changes.","partners":"Not specified","customers":"Not specified","investors":"ווליו בייס","confidence":8,"key_topics":"Stock Issuance, Financial Losses, Personnel Changes, Cannabis Production, Regulatory Issues","date_of_event":"Not specified","valuation_amount":"7 million shekels","impact_on_company":"growth-negative","investment_amount":"6 million shekels","structured_issues":"Investment, Layoffs","acquisition_amount":"Not applicable","structuredIssuesShow":"#Investment, Layoffs","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"cUVzZwYj9pU1hgAorBDy5WwP0qRlySRk8H79aKMJTh7wzWcXLRlNlA","news_summary":"פארמוקן מנפיקה במחירי סוף עונה והמניה התרסקה ב־27% | כלכליסט","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"87b73411-8fbf-426b-bef4-d92de1326d7b","date":"Jul 17, 2022","link":"https://www.globes.co.il/news/article.aspx?_atscid=7_134353_204082920_2236088_0_Txtetaxjxdshwhus8sp&did=1001418238","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Management Changes, Layoffs","company":"פארמוקן","layoffs":"N/A","summary":"Pharmocann, an Israeli cannabis company, is facing a crisis as its stock plummets by approximately 16% following the discovery of a fungus in some of its raw materials. The company also announced the immediate departure of its CEO, Gil Hovav, who will be replaced by Liron Halfon, a director in the company. Pharmocann has been struggling to compete in the new cannabis market, with its stock losing 83% of its value in the past year. The company reported a heavy loss of NIS 19.3 million in 2021, despite similar revenues to 2020. The companys revenue in Israel is now threatened by the fungus, making it difficult to see how Pharmocann can recover from this crisis.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":8,"key_topics":["Cannabis","Management Change","Fungus Contamination","Financial Loss","Market Competition"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-negative","investment_amount":"N/A","structured_issues":["Management Changes"],"acquisition_amount":"N/A","structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"dXI7TQmjsQSdl58W7MIBTIaZvOz0HrzG1PXu7HulaoDxiUZx1VTwSQ","news_summary":"פטרייה חדרה לקנאביס של פארמוקן; המנכ\"ל עזב במפתיע","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4e854612-d27b-4965-a6d1-bd07e07e91c4","date":"Apr 28, 2022","link":"https://www.sponser.co.il/Article.aspx?_atscid=7_134353_204082920_2189556_0_Txtetaxjxdshwhus8sp&ArticleId=108330","source":"www.sponser.co.il","visible":1,"analysis":{"tags":"expansion","company":"פארמוקן גלובל","layoffs":null,"summary":"פארמוקן גלובל, a leading medical cannabis company in Israel, has signed an agreement with Plantis Agro. Plantis will grow selected strains in a new facility using innovative technology, similar to the strains grown by Pharmocan. The agreement requires Plantis to provide Pharmocan with a minimum of 4 tons of results over a period of 3 years. Initial sales from commercial cultivation at Plantis are expected to take place in the fourth quarter of 2022. Pharmocan estimates that the total revenue over the duration of the agreement will be around 60 million NIS. This facility will be the third where Pharmocan grows its unique strains, in addition to its sites in Tzippori and Ein Harod. The agreement will allow Pharmocan to expand its production capacity to up to 7 tons per year.","partners":["פלאנטיס אגרו"],"customers":null,"investors":null,"confidence":9,"key_topics":["פארמוקן","פלאנטיס","גידול","תוצאות","הסכם"],"date_of_event":"2022-04-27","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"aTkWugJmJGCXamJvw2Gnf0UKRQJadBsZHdNzpAvKssMHbccQkd3he4","news_summary":"פארמוקן מרחיבה את כושר הייצור","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e40aa5ab-2a9c-4998-9fe3-904001c45978","date":"Nov 18, 2021","link":"https://www.calcalist.co.il/market/article/hkpnk3qof?_atscid=7_134353_204082920_2035693_0_Txtetaxjxdshwhus8sp","source":"www.calcalist.co.il","visible":1,"analysis":{"tags":"Management Changes, Cannabis","company":"Pharmocann Global","layoffs":null,"summary":"Pharmocann Global, a medical cannabis company listed on the Tel Aviv Stock Exchange, has appointed former CEO of Sheba and Hadassah hospitals, Prof. Zeev Rotstein, as chairman of the board. Rotstein will replace outgoing chairman Danny Gilerman. In addition to his role at Pharmocann, Rotstein will also serve as president and head of the scientific committee at EMP, a company developing cannabis-based drugs. The two roles are separate and the companies are different in nature. Pharmocann is involved in the production, marketing, and distribution of medical cannabis, while EMP is focused on drug development.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":"Management Appointment, Cannabis Industry","date_of_event":null,"valuation_amount":"65.8 million shekels","impact_on_company":"growth-positive","investment_amount":null,"structured_issues":"Management Changes","acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"BU6v8usIdKBYNtPy9rE3J0SsGNZMLPDjGtb5PPnmT7B8fulW8Ar3md","news_summary":"קנאביס, טייק 2: פרופ' זאב רוטשטיין יעמוד גם בראש פארמוקן  כלכליסט","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d0bdae82-30ae-420e-85de-f79c146d2547","date":"Nov 8, 2021","link":"https://en.globes.co.il/en/article-pharmocann-teams-with-shamir-institute-on-magic-mushrooms-1001390135","source":"en.globes.co.il","visible":1,"analysis":{"tags":"research and development","company":"Pharmocann","layoffs":null,"summary":"Pharmocann, an Israeli cannabis company, has announced a joint venture with the Shamir Research Institute to research and develop psychedelic drugs based on psilocybin mushrooms. The company will be majority-owned by Pharmocann and will focus on using psilocybin to treat depression and Alzheimers disease. Pharmocann has already started cultivating different strains of mushrooms for research purposes. The joint company will benefit from the Shamir Research Institutes expertise in psilocybin mushroom research. Pharmocann will invest $110,000 in the joint venture and receive exclusive rights to the institutes intellectual property related to mushrooms. The announcement has a positive impact on Pharmocanns growth prospects.","partners":["Shamir Research Institute"],"customers":null,"investors":null,"confidence":8,"key_topics":["psilocybin mushroom-based drugs","Alzheimers","depression","research and development","magic mushrooms"],"date_of_event":"November 8, 2021","valuation_amount":"NIS 67 million","impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"NwIoeKpmuP2yWcEZ1329Lmkm4ikthIIjYjdDiyCarTd9ekh5L4jj32","news_summary":"Pharmocann teams with Shamir Institute on magic mushrooms","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"b1173963-dfcb-4ceb-99bb-21419f8368cc","date":"May 31, 2021","link":"http://www.talniri.co.il/marketnews/article.asp?_atscid=7_134353_204082920_1881966_0_Txtetaxjxdshwhus8sp&mp=93&cat=4&id=102649","source":"www.talniri.co.il","visible":1,"analysis":{"tags":"financial performance","company":"GMP-���","summary":"GMP-��� reported a 76% decrease in revenue in 2021. The companys financial performance declined, with a 0.4% decrease in profit and a 0.2% decrease in revenue. The article discusses the challenges faced by the company and the impact on its growth. The companys customer base has been affected, and it has also experienced a decrease in investment. The article does not mention any specific partners or customers. The date of the event described in the article is not provided. The confidence level of the answer is 7.","investors":null,"key_topics":["financial performance","customer growth","investment"],"impact_on_company":"growth-negative","structured_issues":["Customers","Investment"],"structuredIssuesShow":"#Customers  #Investment","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"7QKQ8JgZgufAAGwrgXzWHEnvc0UKCD1FYg8j3WRrCFrROP70c3edks","news_summary":"פארמוקן מדווחת על תוצאותיה הכספיות לרבעון הראשון של 2021","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"b892a259-a737-4c39-b425-733c45c9c025","date":"Nov 27, 2018","link":"https://globenewswire.com/news-release/2018/11/27/1657317/0/en/WeedMD-Exports-Cannabis-Genetics-to-Israel-s-Pharmocann.html","source":"globenewswire.com","visible":1,"analysis":{"tags":"expansion","company":"WeedMD Inc.","layoffs":null,"summary":"WeedMD Inc., a cannabis producer and distributor, has exported its cannabis genetics to Israels Pharmocann, a medical cannabis producer. This move strengthens Pharmocanns genetics library and expands WeedMDs list of international genetics customers. WeedMD and Pharmocann share a goal of producing premium brands for patients. WeedMD is a federally-licensed producer and distributor of cannabis and cannabis oil in Canada. They operate two facilities and have a multi-channeled distribution strategy. The date of the event described in the article is November 27, 2018.","partners":["Pharmocann"],"customers":null,"investors":null,"confidence":8,"key_topics":["Genetics","Cannabis","Israel","Pharmocann","Medical cannabis"],"date_of_event":"2018-11-27","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Akq9xs1ux6t2LcnjBJhnr4LeMCAdveXrqRkbUfZ811dABktr7meSu8","news_summary":"WeedMD Exports Cannabis Genetics to Israel's Pharmocann","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":8,"techcommunityinvolvement":null,"mediagallery":[{"id":"0ae15aac-d8ea-47a0-91b9-d185777c7199","timestamp":"2017-06-14 13:19:16.000000","resources_type":2,"resources_title":"Interview","resources_file_name":"-kF4PNE4MI8","alt":"Interview logo","imageurl":"https://img.youtube.com/vi/-kF4PNE4MI8/0.jpg","url":"http://youtu.be/-kF4PNE4MI8"},{"id":"ed1e3b4f-85cc-4a6b-8a42-d9b2598acfff","timestamp":"2017-06-14 13:18:46.000000","resources_type":2,"resources_title":"Introduction","resources_file_name":"KHm5JU09NZI","alt":"Introduction logo","imageurl":"https://img.youtube.com/vi/KHm5JU09NZI/0.jpg","url":"http://youtu.be/KHm5JU09NZI"}],"tags":["pharmaceuticals","medical-cannabis","pharma-companies","agtech","medical-products","cannabis"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA","kRvONPXaUfx3z0k67EYy3WxgWbSmbPpmmUpElhmgEvc1wB1l2Ao7j8","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","mHtoryFWdL28IY7Pf1iYWt3iB1Y6DLFcx3jfEl50XWk1gcEKfNMiF2","mHtoryFWdL28IY7Pf1iYWt3iB1Y6DLFcx3jfEl50XWk1gcEKfNMiF2","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuMqZMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2C"],"productstage":"Released","products":[],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":863314,"marketcapitaldate":"2023-07-01T22:00:23.000Z","funding":{"investors":1,"lastfunding":"$690K","totalrounds":1,"fundingstage":"Public","totalfunding":"$690K","publicinvestors":1,"lastpublicfunding":690000,"totalpublicrounds":1,"totalpublicfunding":690000},"team":[{"name":"Luana  Neumann-Schlosser","email":"luana@pharmocann.com","phone":"","gender":"Female","userid":"vv6iKfPdD7MG9A5tkoF5y3nEVxXmAyxrWUesOzmlq8twxOqjEEHwHc","bounced":true,"claimed":null,"founder":0,"urlname":"luana-neumann-schlosser","visible":1,"memberid":"ZGLMO23Yy2fzqF6hFLFmOORS9nTUr24TyOltEtG1GXJidKpC2rqQT7","position":"VP Marketing & Sales ","last_name":"Neumann-Schlosser","claimtoken":"VIvthygN9Pd6nbb5Pg7JPiQC5AnJQHyJMTb3PBKHixezyn07ljik0O","first_name":"Luana ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/luana-neumann-schlosser-157ab535/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2022-09-15 18:47:20.000000","initials":"LN","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Din  Kaniuk ","email":"din@pharmocann.com","phone":"","gender":"Male","userid":"wgMMKJrqYR4IyVmiHwmBaqDDichQt8GI5pMCeFayAkq5wM8jB6v6SQ","bounced":true,"claimed":null,"founder":0,"urlname":"din-kaniuk","visible":1,"memberid":"O5gKDKsQhqgo3bYOr9irys1CbSqqlQk6lZxczVDGgR5tiHuMykvKiy","position":"Business Development Manager","last_name":"Kaniuk ","claimtoken":"bAoAHOBTcV2QaTkyh3jqbZy9iqLbvj9FT93xmCDRlIupQQzKaafNXM","first_name":"Din ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/din-kaniuk-633343180/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2022-09-15 18:46:45.000000","initials":"DK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverifydate":"2019-11-18T00:00:00.000Z","crunchbaseid":"pharmocann","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Sharon Zaks","creator_email":"sharon1337@gmail.com","createdate":"2017-06-14T00:00:00.000Z","biverification":"Natalia Golczar","sectorverification":"Natalia Golczar","affiliatedOrganizations":null,"timeline":[{"id":"4W2Zhytd8b9Z2wd0N09rAlaq1TFnb0dlmFyvwiNaNPvTdGQZzNX660","date":"Apr 2019","amount":"$690K","source":"http://www.cybele.co.il/?PageId63","eventtype":"FundingRoundEvent","investment":[{"name":"Cybele Holdings","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/cybele-holdings","logokey":null,"tagline":"","urlname":"/investor_page/cybele-holdings","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODY5Y3UCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"zwLR7M6BCiRbY3eDpflO7VlkYHfkjvmVdYIugXgMq7MSYae66umqPr","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":690000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"cENTOtVwJRRbXekeJNdxKA7eDyXPFmsMFInNCwRVH3A67kWe4ztUwh","date":"Dec 2018","amount":"Undisclosed","source":"https://www.calcalist.co.il/market/article/bjgo00r3es","ticker":"PMCN","eventtype":"ReverseMergerEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","acquiredcompany_reverse":"Medical Compression Systems","acquiredcompany_reverse_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ7bs4YIDA","acquiredcompany_reverse_type":"Foreign Startup","acquiredcompany_reverse_hidden":true,"acquiredcompany_reverse_fullurl":"/foreign_startup/medical-compression-systems-mcs","acquiredcompany_reverse_logokey":"$qDWINgHZx55M7o06EJMPfg6qveWd1BvGNABXpTJ2uY1xuTEPWPzd5a","acquiredcompany_reverse_urlname":"/foreign_startup/medical-compression-systems-mcs","acquiredcompany_reverse_homepage":"","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","acquiredcompany_reverse_logourl":"https://storage.googleapis.com/clean-finder-353810/$qDWINgHZx55M7o06EJMPfg6qveWd1BvGNABXpTJ2uY1xuTEPWPzd5a","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":null,"valuationnumber":null}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"4/2008","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Pharmocann","logourl":"https://storage.googleapis.com/clean-finder-353810/$zGBwzdybzU8cf5K2lIr3OMCQsqhWLCJbPwIuhVWix3KsnBPYY2ykHA","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$zGBwzdybzU8cf5K2lIr3OMCQsqhWLCJbPwIuhVWix3KsnBPYY2ykHA","seoabout":"Pharmocann develops and produces Israeli medical cannabis on a farm located in the valley of Jezreel, the Galilee. The farm has hothouses for cannabis grow...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":2,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Cannabis","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","classificationName":"sectorclassification"},{"depth":1,"name":"Agriculture & Food Technologies","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA","classificationName":"sectorclassification"},{"depth":2,"name":"Ag Tech","queryString":"sectorclassification=kRvONPXaUfx3z0k67EYy3WxgWbSmbPpmmUpElhmgEvc1wB1l2Ao7j8","classificationName":"sectorclassification"},{"depth":3,"name":"Farm Equipment & Treatment","queryString":"sectorclassification=mHtoryFWdL28IY7Pf1iYWt3iB1Y6DLFcx3jfEl50XWk1gcEKfNMiF2","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Raw Materials","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuMqZMJDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA","SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA>Ag Tech#kRvONPXaUfx3z0k67EYy3WxgWbSmbPpmmUpElhmgEvc1wB1l2Ao7j8","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA>Ag Tech#kRvONPXaUfx3z0k67EYy3WxgWbSmbPpmmUpElhmgEvc1wB1l2Ao7j8>Farm Equipment & Treatment#mHtoryFWdL28IY7Pf1iYWt3iB1Y6DLFcx3jfEl50XWk1gcEKfNMiF2","SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA>Ag Tech#kRvONPXaUfx3z0k67EYy3WxgWbSmbPpmmUpElhmgEvc1wB1l2Ao7j8>Farm Equipment & Treatment#mHtoryFWdL28IY7Pf1iYWt3iB1Y6DLFcx3jfEl50XWk1gcEKfNMiF2","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA>Raw Materials#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuMqZMJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Medical Cannabis#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Medical Cannabis#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA|1:>SectorClassificationModel/Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA|2:>SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA/Ag Tech#kRvONPXaUfx3z0k67EYy3WxgWbSmbPpmmUpElhmgEvc1wB1l2Ao7j8|3:>SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA>Ag Tech#kRvONPXaUfx3z0k67EYy3WxgWbSmbPpmmUpElhmgEvc1wB1l2Ao7j8/Farm Equipment & Treatment#mHtoryFWdL28IY7Pf1iYWt3iB1Y6DLFcx3jfEl50XWk1gcEKfNMiF2|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA|2:>TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA/Raw Materials#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuMqZMJDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Medical Cannabis","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Medical Cannabis"}]}]},{"title":"Agriculture & Food Technologies","key":"0-1","path":"SectorClassificationModel>Agriculture & Food Technologies","children":[{"title":"Ag Tech","key":"0-1-0","path":"SectorClassificationModel>Agriculture & Food Technologies>Ag Tech","children":[{"title":"Farm Equipment & Treatment","key":"0-1-0-0","path":"SectorClassificationModel>Agriculture & Food Technologies>Ag Tech>Farm Equipment & Treatment"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]}],"coreTechnology":[{"title":"Materials & Substances","key":"0-0","path":"TechnologyClassificationModel>Materials & Substances","children":[{"title":"Raw Materials","key":"0-0-0","path":"TechnologyClassificationModel>Materials & Substances>Raw Materials"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Cannabis","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gJDA","classificationName":"sectorclassification"},{"depth":1,"name":"Agriculture & Food Technologies","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA","classificationName":"sectorclassification"},{"depth":2,"name":"Ag Tech","queryString":"sectorclassification=kRvONPXaUfx3z0k67EYy3WxgWbSmbPpmmUpElhmgEvc1wB1l2Ao7j8","classificationName":"sectorclassification"},{"depth":3,"name":"Farm Equipment & Treatment","queryString":"sectorclassification=mHtoryFWdL28IY7Pf1iYWt3iB1Y6DLFcx3jfEl50XWk1gcEKfNMiF2","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Raw Materials","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuMqZMJDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Medical Cannabis","Agriculture & Food Technologies","Ag Tech","Farm Equipment & Treatment"],"coreTechnology":["Materials & Substances","Raw Materials"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"cENTOtVwJRRbXekeJNdxKA7eDyXPFmsMFInNCwRVH3A67kWe4ztUwh","date":"Dec 2018","amount":"Undisclosed","source":"https://www.calcalist.co.il/market/article/bjgo00r3es","ticker":"PMCN","eventtype":"ReverseMergerEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","acquiredcompany_reverse":"Medical Compression Systems","acquiredcompany_reverse_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ7bs4YIDA","acquiredcompany_reverse_type":"Foreign Startup","acquiredcompany_reverse_hidden":true,"acquiredcompany_reverse_fullurl":"/foreign_startup/medical-compression-systems-mcs","acquiredcompany_reverse_logokey":"$qDWINgHZx55M7o06EJMPfg6qveWd1BvGNABXpTJ2uY1xuTEPWPzd5a","acquiredcompany_reverse_urlname":"/foreign_startup/medical-compression-systems-mcs","acquiredcompany_reverse_homepage":"","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","acquiredcompany_reverse_logourl":"https://storage.googleapis.com/clean-finder-353810/$qDWINgHZx55M7o06EJMPfg6qveWd1BvGNABXpTJ2uY1xuTEPWPzd5a","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":null,"valuationnumber":null}],"privateequityfunding":[{"id":"4W2Zhytd8b9Z2wd0N09rAlaq1TFnb0dlmFyvwiNaNPvTdGQZzNX660","date":"Apr 2019","amount":"$690K","source":"http://www.cybele.co.il/?PageId63","eventtype":"FundingRoundEvent","investment":[{"name":"Cybele Holdings","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/cybele-holdings","logokey":null,"tagline":"","urlname":"/investor_page/cybele-holdings","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODY5Y3UCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"zwLR7M6BCiRbY3eDpflO7VlkYHfkjvmVdYIugXgMq7MSYae66umqPr","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":690000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}